| Business Summary | | Chad
Therapeutics,
Inc.
was
incorporated
in
1982
to
develop,
produce
and
market
respiratory
care
devices
designed
to
improve
the
efficiency
of
oxygen
delivery
systems
for
both
home
and
hospital
treatment
of
patients
who
require
supplemental
oxygen.
The
Company
was
organized
to
pursue
the
development
and
marketing
of
devices
that
improve
the
efficiency
of
systems
used
to
administer
oxygen
to
patients
requiring
supplemental
oxygen.
These
are
primarily
patients
suffering
from
chronic
obstructive
pulmonary
diseases. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | CTU
is
in
the
business
of
developing,
producing
and
marketing
respiratory
care
devices
designed
to
improve
the
efficiency
of
oxygen
delivery
systems
for
home
health
care
and
hospital
treatment
of
patients
suffering
from
pulmonary
diseases.
For
the
three
months
ended
6/30/01,
net
sales
rose
63%
to
$4.8
million.
Net
income
totaled
$13
thousand
vs.
a
loss
of
$720
thousand.
Results
reflect
higher
sales
of
the
new
OXYMATIC
400
series
and
an
increase
in
interest
income. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Thomas Jones, 56 Vice
Chairman and CEO | $205K | Earl Yager, 54 Exec.
VP, CFO, Chief Operating Officer, Sec., Director | 146K | Alfonso Del Toro, 42 VP-
Manufacturing | 125K | Kevin McCulloh, 39 VP-
Engineering | 103K | Oscar Sanchez, 57 VP-Bus.
Devel. | 137K | Dollar amounts are as of 31-Mar-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|